Health Secretary Robert F. Kennedy Jr. has launched an FDA review of mifepristone, the drug used in two-thirds of all abortions. Advocates warn that restrictions could limit access even in states where abortion remains legal, sparking debate over reproductive rights.
Breakdown
- The FDA has begun a review of mifepristone, a drug used in most U.S. abortions.
- Medical experts and organizations maintain that mifepristone is safe and effective. 29s
- The review was prompted by a report from a conservative think tank alleging higher complication rates. 1m 17s
- Other data sources show serious complications from mifepristone are much rarer than claimed in the report. 1m 36s
- Potential policy changes could restrict access to mifepristone, though a full ban would likely face legal challenges. 1m 46s